Falling stock markets and high shop prices hit US consumer confidence; rate cut hopes lift Wall Street – as it happened

US consumer sentiment fell to 51 in November from 53.6 as households report sharply weaker current finances and durables buying (both down more than 10%), with wealthier consumers hit by recent stock market declines; compounding the data gap, the BLS canceled October’s CPI release due to the government shutdown. Comments from New York Fed president John Williams that there is room for a near-term quarter-point cut lifted risk assets—the S&P rallied roughly 1–1.5% (about 70 points) and bitcoin briefly hit an intraday low near $84,326—even as other Fed officials remained cautious. European equities logged their biggest weekly fall since July (STOXX600 down to ~562.1), while corporate news showed targeted resilience: AstraZeneca announced a $2bn Maryland manufacturing expansion (part of a $50bn US plan, supporting ~2,600 jobs) and Babcock flagged positive export prospects alongside a 5% revenue rise to £2.5bn, illustrating pockets of capex and defence strength amid broader macro uncertainty.

Analysis

The University of Michigan consumer sentiment index fell to 51 in November from 53.6 in October, with current personal finances and buying conditions for durables each plunging more than 10%; wealthier households saw sentiment drop about 2 index points as recent stock declines weighed on their outlook. Surveys’ director Joanne Hsu notes lingering frustration over persistent high prices and weakening incomes, a dynamic amplified by the Bureau of Labor Statistics’ cancellation of October’s CPI release, which creates a near-term data vacuum for inflation tracking.

Markets moved erratically on mixed signals from central bankers: New York Fed president John Williams said there is room for a near-term quarter-point cut, lifting the S&P 500 roughly 1–1.5% (about 70 points to 6,609) and raising December cut odds to ~70% on CME FedWatch, while Boston Fed President Susan Collins signalled skepticism; bitcoin hit an intraday low near $84,326 (down ~3.3%) before partial recovery. The ambiguity in Fed messaging combined with missing CPI data increases short-term volatility and raises the premium on event risk.

At the sector level there are divergent signals: AstraZeneca announced a $2bn Maryland manufacturing expansion (part of a $50bn US plan) supporting ~2,600 jobs, and Babcock reported a 5% revenue increase to £2.5bn with improved cash generation, underscoring selective capex and defence resilience amid broader weakness. European equities logged their worst week since July (STOXX600 ~562.1), reinforcing a tactical case for defensive and quality names until clearer macro datapoints and Fed guidance emerge.

Key Decisions for Investors

• Reduce or hedge exposure to consumer cyclicals and discretionary names in the near term given a >10% deterioration in durables buying conditions and weakening incomes
• Favor selective defensive and quality equities exposed to structural demand: consider increasing conviction in healthcare names with active capex (eg, AstraZeneca) and defence contractors showing cash resilience (eg, Babcock) , but size positions given operational and execution risk
• Maintain tactical option protection or reduce beta ahead of the rescheduled CPI and FOMC communications given heightened volatility from mixed Fed signals and a missing October CPI print
• Treat the market rally driven by higher odds of a December cut as conditional — be prepared to add risk on confirmed policy easing but avoid full re-risking until incoming inflation and payroll data confirm a durable disinflation trend
• Trim or hedge crypto allocations after bitcoin’s intraday drop and negative sentiment for GBTC/BITO, at least until macro drivers and risk appetite stabilize